Romidepsin - Celgene Corporation
At a glance
- Drug Originator Astellas Pharma
- Drug Licenced by Celgene Corporation
- Drug Class Antineoplastics; Cytostatic antibiotics; Depsipeptides; Small molecules
- Mechanism of Action Histone deacetylase inhibitors
- USA Patent Applicants BRISTOL-MYERS
- USA Patents 3
- NDAs 1
- Patent Applications 4,652
Table of Contents
Disclaimer